Envista (NVST): Margin Gains Lift Guidance More Than Sales

On August 5, 2026, dental supplier Envista Holdings (NVST) raised its full-year outlook after second-quarter core sales grew 5.0% and adjusted EBITDA margin expanded 230 basis points to 14.7%. The guidance revision reflects operating efficiency gains rather than broad top-line acceleration.

Profit Targets Are Moving Faster Than Revenue

Envista's updated full-year 2026 guidance highlights that operational split: core-sales growth of 3.5% to 4.5% contrasts with adjusted EBITDA growth of 11% to 14% and adjusted EPS of US$1.50 to US$1.55. Management also targets full-year free-cash-flow conversion of approximately 100% of adjusted net income. The gap between top-line expectations and profit targets confirms that margin execution is driving the revised outlook.

Product line performance remains uneven. Equipment and Consumables delivered 8.5% core growth, Specialty Products & Technologies grew 3.1%, and Spark clear aligners expanded at a double-digit rate. These segments keep revenue within management's target range without establishing broader growth momentum.

Profitability Strength Is Outpacing the Growth Read

Per StockLens's model, as of August 10, 2026, Envista carries a Profitability score of 89 alongside a Growth score of 67. An Operating Margin factor of 9.9%, supported by expense discipline, reinforces the stronger profitability assessment.

The growth domain displays clear internal divergence. EPS Growth (YoY) reached 90.3%, propelled by operating-margin expansion, but Forward Revenue Growth (Est.) stands at 1.7%. Meanwhile, FCF Growth (YoY) declined 9.9%, underscoring the gap between accounting profits and cash generation and making full-year cash conversion critical. As context, Envista holds a Composite score of 82 and a Solid rating.